Risk of Fracture During Androgen Deprivation Therapy Among Patients With Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies

Risk of Fracture During Androgen Deprivation Therapy Among Patients With Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies

Background: Androgen deprivation therapy (ADT) suppresses the production of androgen, and ADT is broadly used for intermediate or higher risk disease including advanced and metastatic cancer. ADT is associated with numerous adverse effects derived from the pharmacological properties. Previous meta-a...

Full description

Bibliographic Details
Main Authors:	Cheng Chih Wu, Po Yen Chen, Shih Wei Wang, Meng Hsuan Tsai, Yu Chin Lily Wang, Ching Ling Tai, Hao Lun Luo, Hung-Jen Wang, Chung Yu Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	fracture prostate cancer antiandrogen androgen deprivation therapy luteinizing hormone-releasing hormone agonist
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.652979/full

Similar Items

Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
by: Koji Yoshimura, et al.

ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN
by: A. S. Markova, et al.
Published: (2014-07-01)

ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN
by: A. S. Markova, et al.
Published: (2014-07-01)

The effects of androgens on steroidogenesis in the ovary of Atlantic croaker (Micropogonias undulatus) : mechanism of action, the biochemical characterization of a membrane androgen receptor, and the chronic effects of exposure to an environmental antiandrogen
by: Braun, Alyssa Maria, 1974-
Published: (2011)

Analyse protéomique des réseaux de signalisation du récepteur aux androgènes modulés par l'Enzalutamide dans le cancer de la prostate résistant à la castration
by: Vélot, Lauriane
Published: (2019)

Hormonal therapy in metastatic prostate cancer: current perspectives and controversies
by: Manish Garg, et al.
Published: (2013-09-01)

Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
by: Eva Estébanez-Perpiñá, et al.
Published: (2021-01-01)

Study the efficacy of herbal formulation Niśāmalakī in animal model of polycystic ovarian disease syndrome
by: Jayshree S Dawane, et al.
Published: (2017-01-01)

Diurnal variation of gonadotropin levels in girls with early stages of puberty
by: Yu Sun Kang, et al.
Published: (2017-09-01)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
by: Tucci M, et al.
Published: (2018-10-01)

HORMONE REFRACTORY PROSTATE CANCER AND ITS DEVELOPMENT DURING ANTIANDROGEN THERAPY
by: S. A. Rakul, et al.
Published: (2014-08-01)

HORMONE REFRACTORY PROSTATE CANCER AND ITS DEVELOPMENT DURING ANTIANDROGEN THERAPY
by: S. A. Rakul, et al.
Published: (2014-08-01)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
by: Aristomenis Anestis, et al.
Published: (2020-01-01)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
by: Miriam Kokal, et al.
Published: (2020-07-01)

Diagnostic evaluation of central precocious puberty in girls
by: Shu-Nin Yeh, et al.
Published: (2021-03-01)

Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats
by: Hyun Yang, et al.
Published: (2018-11-01)

Le blocage androgénique intermittent versus continu dans le traitement du cancer de la prostate
by: Magnan, Sindy
Published: (2015)

Regulation of LH and GnRH secretion during prepubertal development in the bull calf
by: Rodriguez, Rafael Eduardo, 1963-
Published: (1989)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021-07-01)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
by: Liu Nana, et al.
Published: (2012-04-01)

How Does Androgen Deprivation Therapy Affect Mental Health including Cognitive Dysfunction in Patients with Prostate Cancer?
by: Hyung Ho Lee, et al.
Published: (2021-10-01)

Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy
by: Bohnert, A.S.B, et al.
Published: (2022)

Exposure to Multiple Low-Level Chemicals in Relation to Reproductive Hormones in Premenopausal Women Involved in Liquid Crystal Display Manufacture
by: Pau-Chung Chen, et al.
Published: (2013-04-01)

Electrophilic androgen receptor ligands as chemotherapeutic agents for prostate cancer
by: Xu, Huiping
Published: (2004)

Association Between Asthma and Reduced Androgen Receptor Expression in Airways
by: Gaston, B., et al.
Published: (2022)

The role of androgens in the female genital tract
by: Chong, Jessica
Published: (2017)

Hormonal modulation of Leydig cell membrane luteinizing hormone receptors /
by: Hussein, Mohamed Osman
Published: (1986)

The occurrence of skin lesions in patients with androgenization syndromes including the analysis of the results of hormonal tests
by: Mirela Niedzielska, et al.
Published: (2017-08-01)

Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen Loss
by: Sabina Bhatta, et al.
Published: (2018-09-01)

Plasticity of Anterior Pituitary Gonadotrope Cells Facilitates the Pre-Ovulatory LH Surge
by: Colin M. Clay, et al.
Published: (2021-02-01)

Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer
by: Kyungsuk Jung, et al.
Published: (2018-08-01)

Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer
by: Hu L, et al.
Published: (2020-06-01)

Hypothalamic KiSS1/GPR54 Gene Expressions and Luteinizing Hormone Plasma Secretion in Morphine Treated Male Rats
by: Homayoun Khazali, et al.
Published: (2018-10-01)

Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty
by: Dong-Min Lee, et al.
Published: (2019-03-01)

Hormone naïve prostate cancer: predicting and maximizing response intervals
by: Judd W Moul
Published: (2015-01-01)

Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women
by: Ranganath Muniyappa, et al.
Published: (2017-12-01)

Utility of Ovarian Tumour Marker Cancer Antigen-125 and Endocrine Hormonal Status in Polycystic Ovary Syndrome
by: Shahid Akbar Mujawar, et al.
Published: (2018-10-01)

Regulation of prolactin and changes in prolactin and growth hormone in osmoregulation, metabolism, and reproduction in the tilapia, Oreochromis mossambicus
by: Weber, Gregory Martin
Published: (2009)

Structural and functional evolution of gonadotropin-releasing hormone (GnRH) and pituitary adenylate cyclase-activating polypeptide (PACAP) in chordates
by: Adams, Bruce Alexander
Published: (2008)

Structure and function of gonadotropin-releasing hormone in the Thai catfish, Clarias macrocephalus
by: Ngamvongchon, Somsri
Published: (2018)